The use of patient-reported outcome measures—the gold standard in quality measurement—is crucial to building a patient-centered, value-based care system.
Erin Crum, MPH
Advertisement
Articles by Erin Crum, MPH
To ease the administrative burden, CMS has facilitated the collection and processing of information by allowing the formulation of Qualified Clinical Data Registries, which collect data on quality measures from individual providers and group practitioners.
Nearly a decade ago, CMS started healthcare providers on the road to value-based care. Along the way, we have seen a variety of quality programs that impact community oncologists.
Advertisement
Latest Updated Articles
McKesson's Patient-Reported Outcomes Measure Will Track Improvements in Health-Related Social NeedsPublished: October 16th 2024 | Updated:
MIPS Will Hold Practices to Higher StandardsPublished: October 26th 2016 | Updated:
- Qualified Clinical Data Registries Help Practices Meet MIPS Requirements
Published: May 26th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
4
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
5